C08B 37/0015
Inclusion compounds, i.e. host-guest compounds
Official title: {Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes}
C08B37/0015 (Inclusion compounds, i.e. host-guest compounds) appears on 570 US grants and 715 published applications in this corpus.
Search patents in C08B- Granted patents
- 570
- Published applications
- 715
- Assignees
- 416
- Inventors
- 1,471
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 4 | 0 |
| 1984 | 8 | 0 |
| 1985 | 6 | 0 |
| 1986 | 9 | 0 |
| 1987 | 11 | 0 |
| 1988 | 7 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 9 | 0 |
| 1992 | 4 | 0 |
| 1993 | 14 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 8 | 0 |
| 1997 | 16 | 0 |
| 1998 | 14 | 0 |
| 1999 | 6 | 0 |
| 2000 | 14 | 0 |
| 2001 | 6 | 0 |
| 2002 | 5 | 10 |
| 2003 | 10 | 10 |
| 2004 | 5 | 9 |
| 2005 | 7 | 7 |
| 2006 | 4 | 8 |
| 2007 | 3 | 24 |
| 2008 | 4 | 10 |
| 2009 | 8 | 34 |
| 2010 | 10 | 30 |
| 2011 | 10 | 30 |
| 2012 | 6 | 22 |
| 2013 | 18 | 30 |
| 2014 | 13 | 31 |
| 2015 | 15 | 39 |
| 2016 | 24 | 30 |
| 2017 | 24 | 39 |
| 2018 | 23 | 42 |
| 2019 | 44 | 41 |
| 2020 | 41 | 54 |
| 2021 | 31 | 53 |
| 2022 | 27 | 37 |
| 2023 | 23 | 37 |
| 2024 | 11 | 32 |
| 2025 | 28 | 36 |
| 2026 | 7 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical compositions comprising meloxicam5 May 2026US 12,616,752 B2Axsome Therapeutics, Inc.
- Cyclodextrin-polyoxometalate ionic liquid inclusion complex flame retardant additive for making a low smoke zero halogen compound5 May 2026US 12,617,874 B2Corning Incorporated
- Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative24 Mar 2026US 12,582,662 B2Zoetis Services LLC
- Pharmaceutical compositions comprising meloxicam17 Feb 2026US 12,551,488 B2Axsome Therapeutics, Inc.
- Pharmaceutical compositions comprising meloxicam17 Feb 2026US 12,551,489 B2Axsome Therapeutics, Inc.
- Pharmaceutical compositions comprising meloxicam8 Oct 2026US 2026/0306635 A1Axsome Therapeutics, Inc.
- Cyclodextrin-poly (beta amino ester) macromolecules for nanoparticle drug delivery23 Jul 2026US 2026/0207508 A1
- Trisulfide compound and clathrate thereof23 Jul 2026US 2026/0209201 A1Kyowa Pharma Chemical Co., Ltd.
- Composite polymer material, method for producing same, and optical material23 Jul 2026US 2026/0209518 A1Shin-Etsu Chemical Co., Ltd.
- Use of cell membrane-bound signaling factors16 Jul 2026US 2026/0199218 A1Aivita Biomedical, Inc.
Most cited
By later US patents
- Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives221US 4,596,795 AThe United States of America, as represented by the Secretary, Dept. of Health and Human Services · 1986
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Pharmaceutical composition and its nasal or vaginal use203US 4,659,696 ATakeda Chemical Industries, Ltd. · 1987
- Gel compositions containing metronidazole133US 6,468,989 B1Dow Pharmaceutical Sciences, Inc. · 2002
- Pharmaceutical compositions comprising meloxicam117US 9,821,075 B2Axsome Therapeutics, Inc. · 2017